World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 40 5489 5074 2071 1863 71 8997

Larisa V. Gubareva publications per year

The chart shows the history of publications by Larisa V. Gubareva between 1988 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Larisa V. Gubareva published across 38 years, from 1988 to 2025, averaging 1.9 papers a year. Output peaked at 8 publications in 2010. 2 of the 73 publications appeared in the last two years.

No. of publications
2 4 6 8
Bar chart. Horizontal axis: year, 1988 to 2025. Vertical axis: number of publications, 0 to 8. Peak 8 publications in 2010. 1988: 1 publication 1989: 0 publications 1990: 0 publications 1991: 2 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 3 publications 1996: 1 publication 1997: 1 publication 1998: 2 publications 1999: 0 publications 2000: 2 publications 2001: 4 publications 2002: 5 publications 2003: 0 publications 2004: 3 publications 2005: 3 publications 2006: 1 publication 2007: 1 publication 2008: 3 publications 2009: 6 publications 2010: 8 publications 2011: 6 publications 2012: 1 publication 2013: 2 publications 2014: 2 publications 2015: 7 publications 2016: 1 publication 2017: 3 publications 2018: 2 publications 2019: 1 publication 2020: 0 publications 2021: 0 publications 2022: 0 publications 2023: 0 publications 2024: 1 publication 2025: 1 publication
1988 2025

73 publications in total across all disciplines

View publications per year as a table
Larisa V. Gubareva: publications per year, 1988 to 2025
Year Publications
1988 1
1989 0
1990 0
1991 2
1992 0
1993 0
1994 0
1995 3
1996 1
1997 1
1998 2
1999 0
2000 2
2001 4
2002 5
2003 0
2004 3
2005 3
2006 1
2007 1
2008 3
2009 6
2010 8
2011 6
2012 1
2013 2
2014 2
2015 7
2016 1
2017 3
2018 2
2019 1
2020 0
2021 0
2022 0
2023 0
2024 1
2025 1
Total 73
Download as CSV

Larisa V. Gubareva publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Larisa V. Gubareva sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 65–74 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 71 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29 71
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Larisa V. Gubareva D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Larisa V. Gubareva sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 40 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 40 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30 40
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Larisa V. Gubareva is affiliated with the Centers for Disease Control and Prevention in the United States. Their research focuses primarily on medical and molecular biological aspects of infectious diseases, with several contributions to the field of epidemiology.

Their research includes work in the following fields of study:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these areas, their subfields of study include:

  • Epidemiology
  • Molecular Biology
  • Modeling and Simulation

Key topics addressed in their work comprise:

  • Influenza Virus Research Studies
  • Protein Structure and Dynamics
  • COVID-19 epidemiological studies
  • Respiratory viral infections research
  • Metabolomics and Mass Spectrometry Studies

Among their recent papers are the following:

  • Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, 2024, Emerging Infectious Diseases
  • Antiviral Susceptibility Monitoring: Testing Algorithm, Methods, and Findings for Influenza Season, 2023-2024, 2025, SSRN Electronic Journal

Frequent collaborators in research include:

  • Mira C. Patel
  • Ha Nguyen
  • Philippe Noriel Q. Pascua
  • John Steel
  • Rebecca Kondor

Publications by Larisa V. Gubareva appear in venues including:

  • Emerging Infectious Diseases
  • SSRN Electronic Journal

Best Publications

  • Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

    Seema Jain;Lyn Finelli;Michael W. Shaw;Stephen Lindstrom

  • Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

    Rebecca J. Garten;C. Todd Davis;Colin A. Russell;Colin A. Russell;Bo Shu

  • Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

    Anthony E Fiore;Alicia Fry;David Shay;Larisa Gubareva

  • Influenza virus neuraminidase inhibitors

    Larisa V Gubareva;Laurent Kaiser;Frederick G Hayden

  • Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009

    Vivek Shinde;Carolyn B Bridges;Timothy M Uyeki;Bo Shu

  • Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

    Nila J. Dharan;Larisa V. Gubareva;John J. Meyer;Margaret Okomo-Adhiambo

  • Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide

    Varough M. Deyde;Xiyan Xu;Rick A. Bright;Michael Shaw

  • Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

    Tiffany G. Sheu;Varough M. Deyde;Margaret Okomo-Adhiambo;Rebecca J. Garten

  • Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus

    Larisa V. Gubareva;Mikhail N. Matrosovich;Malcolm K. Brenner;Richard C. Bethell

  • Inhaled zanamivir for the prevention of influenza in families

    Frederick G. Hayden;Larisa V. Gubareva;Arnold S. Monto;Thomas C. Klein

  • Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.

    Laurent Kaiser;R. Scott Fritz;Stephen E. Straus;Larisa Gubareva

  • Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

    Larisa V. Gubareva;Laurent Kaiser;Mikhail N. Matrosovich;Mikhail N. Matrosovich;Yee Soo-Hoo

  • Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

    L V Gubareva;M J Robinson;R C Bethell;R G Webster

  • Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

    Michael G. Ison;Larisa V. Gubareva;Robert L. Atmar;John Treanor

  • Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.

    Vasiliy P. Mishin;Frederick G. Hayden;Larisa V. Gubareva

  • Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine

    Stacy L Davlin;Lenee Blanton;Krista Kniss;Desiree Mustaquim

  • Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

    Michael P. Malakhov;Laura M. Aschenbrenner;Donald F. Smee;Miles K. Wandersee

  • Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants

    Larisa V. Gubareva;Robert G. Webster;Robert G. Webster;Frederick G. Hayden

  • Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.

    Unknown

  • Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

    L. Gubareva;M. Okomo-Adhiambo;V. Deyde;A. M. Fry

  • Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.

    Aeron C Hurt;Tawee Chotpitayasunondh;Nancy J Cox;Rod Daniels

  • Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.

    L V Gubareva;R Bethell;G J Hart;K G Murti

  • Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.

    Ha T Nguyen;Alicia M Fry;Larisa V Gubareva

  • Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.

    David M Weinstock;Larisa V Gubareva;Gianna Zuccotti

  • Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015

    Adam Meijer;Helena Rebelo-de-Andrade;Helena Rebelo-de-Andrade;Vanessa Correia;Vanessa Correia;Terry Besselaar

  • Characterization of Influenza A/HongKong/156/97 (H5N1) Virus in a Mouse Model and Protective Effect of Zanamivir on H5N1 Infection in Mice

    Larisa V. Gubareva;Jonathan A. McCullers;Richard C. Bethell;Robert G. Webster

  • Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.

    Larisa V. Gubareva;Robert G. Webster;Robert G. Webster;Frederick G. Hayden

  • Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

    Alicia M Fry;Doli Goswami;Kamrun Nahar;Amina Tahia Sharmin

  • Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.

    Luis Barroso;John Treanor;Larisa Gubareva;Frederick G Hayden

  • Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

    Unknown

  • Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

    Donald F. Smee;Kevin W. Bailey;Min-Hui Wong;Barry R. O’Keefe

  • Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir

    Ha T. Nguyen;Alicia M. Fry;P. Ann Loveless;Alexander I. Klimov

  • In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication

    Warren M. Kati;Debra Montgomery;Robert Carrick;Larisa Gubareva

Frequent Co-Authors

Alicia M. Fry
Alicia M. Fry Emory University
Alexander Klimov
Alexander Klimov Centers for Disease Control and Prevention
Rebecca Garten
Rebecca Garten National Center for Immunization and Respiratory Diseases
John Barnes
John Barnes Centers for Disease Control and Prevention
Xiyan Xu
Xiyan Xu Centers for Disease Control and Prevention
Joseph S. Bresee
Joseph S. Bresee Centers for Disease Control and Prevention
David E. Wentworth
David E. Wentworth Centers for Disease Control and Prevention
Lynnette Brammer
Lynnette Brammer Centers for Disease Control and Prevention
Jacqueline M. Katz
Jacqueline M. Katz Emory University
Stephen Lindstrom
Stephen Lindstrom Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, expanding career options through related online degrees can be a smart move. Fields such as health information management and medical coding offer promising opportunities that align well with a microbiology background.

One career to consider is becoming a certified professional coder, which requires specialized training in medical coding systems. Exploring how to become a certified professional coder can open doors to healthcare administration roles with competitive salaries.

For those interested in broader healthcare data management, pursuing a bachelor of science in health information management salary offers insight into this field’s lucrative potential and growing demand.

To ensure quality education that meets industry standards, consider enrolling in cahiim accredited health information management programs online. These programs provide recognized credentials to advance your career.

Additionally, for those seeking quicker entry into the field, the fastest online medical billing and coding certificate programs offer accelerated pathways to certification, making it easier to start work promptly while leveraging microbiology knowledge in healthcare settings.

Best Scientists Citing Larisa V. Gubareva

Trending Scientists

Recently Published Articles